Dr. Woller’s academic interest is in the arena of thromboembolism and anticoagulation management. With a particular interest in the prevention of venous thromboembolic disease, Dr. Woller is an investigator on multiple ongoing and recently completed clinical trials including two NIH-funded studies (COAG, GIFT) and served as site PI for one (GIFT). Dr. Woller is presently serving as Co-Chair for the American College of Chest Physicians (ACCP) Clinical Practice Guideline that addresses antithrombotic therapy for venous thromboembolic disease, and as was a panelist for the Vascular Access Appropriateness Panel housed at the University of Michigan. Dr. Woller is an invited panelist for the Centers for Disease Control and Prevention (CDC) Risk Assessment Model for the Prevention of Venous Thromboembolic Disease in Medical Patients program.
